Robert Martell insider trades

Open-market stock purchases and sales by Robert Martell, Director at Indaptus Therapeutics, Inc, from SEC Form 4 filings since Sep 14, 2011.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • INDP Indaptus Therapeutics, Inc: other filings, last Jun 10, 2025
  • CRIS Curis Inc: 1 sale, last Jan 20, 2023

Get free alerts when Robert Martell files a new trade →